| Ambetter Health Texas Superior Marketplace Clinical | Navepegritide (TransCon CNP) (CP.PHAR.746) | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Navepegritide (TransCon CNP) (CP.PHAR.746) | |
| Ambetter Health Texas Superior Marketplace Clinical | Plozasiran (ARO-APOC3) (CP.PHAR.721) PEPP | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Plozasiran (ARO-APOC3) (CP.PHAR.721) PEPP | |
| Ambetter Health Texas Superior Marketplace Clinical | Drugs of Abuse: Presumptive Testing (CP.MP.208) | |
| Ambetter Health Texas Superior Marketplace Clinical | E&M Medical Decision-Making (CC.PP.051) | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Drugs of Abuse: Presumptive Testing (CP.MP.208) | |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | E&M Medical Decision-Making (CC.PP.051) | |
| Ambetter Health Texas Superior Marketplace Clinical | Enhanced Code Editing (TX.PP.011-A) | |
| Ambetter Health Texas Superior Marketplace Clinical | Genetic and Molecular Testing Services (TX.PP.551) | |